Mehmet Murat Zerey, Paulo Siqueira do Amaral, Alan Tan. "Whole genome–based ultrasensitive circulating tumor DNA clearance as a biomarker of exceptional outcomes with enfortumab vedotin and pembrolizumab in urothelial carcinoma: Preliminary real-world results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.866